Add BrightSurf on Google Email

Science News for April 23, 2010


$1.7 million keeps McGill on edge

The McGill University researchers will be working on various projects, including cancer research and bone degeneration, using the new funding. The Canada Foundation for Innovation's investment will help develop Canada's global reputation as a place where outstanding research and training is being conducted.

Complete revascularization improves outcomes for CAD patients

A retrospective study found that complete revascularization significantly improved outcomes for patients with coronary artery disease (CAD), with a 3-year mortality rate of 6.6% compared to 14.8% in those with incomplete revascularization. The study also revealed that advanced medical therapy may contribute to improved mortality rates.

SourceWiley·JournalCatheterization and Cardiovascular Interventions·DateApr 23, 2010

Forecasting rates of overweight

A study published in Medical Decision Making predicts that adult US obesity rates will remain stable over the next 10 years. However, certain groups such as black young adults, children aged 6-9, and black children are projected to experience rising overweight rates.

SourceSAGE·JournalMedical Decision Making·DateApr 23, 2010

Making its predators tremble: Multiple defenses act synergistically in aspen

A study on trembling aspen found that phenolic glycosides and extrafloral nectaries are distributed together in the same leaves, contradicting previous assumptions. The presence of extrafloral nectaries is positively correlated with higher levels of chemical defenses, suggesting a complex relationship between these defense mechanisms.

SourceBotanical Society of America·JournalAmerican Journal of Botany·DateApr 23, 2010

Subtle changes in PTEN tumor suppressor gene can determine cancer susceptibility

A new study reveals that even slight reductions in PTEN expression can significantly increase cancer susceptibility in specific tissues, implying that environmental factors like diet and carcinogens may drive tumor development. This finding has implications for the development of diagnostic tests targeted to these gene alterations.

SourceBeth Israel Deaconess Medical Center·JournalNature Genetics·DateApr 23, 2010